T. Rowe Price Associates’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-22,427
| Closed | -$225K | – | 3016 |
|
|
2022
Q3 | $225K | Hold |
22,427
| – | – | ﹤0.01% | 2496 |
|
|
2022
Q2 | $222K | Hold |
22,427
| – | – | ﹤0.01% | 2555 |
|
|
2022
Q1 | $221K | Hold |
22,427
| – | – | ﹤0.01% | 2670 |
|
|
2021
Q4 | $219K | Buy |
22,427
+2,127
| +10% | +$20.8K | ﹤0.01% | 2721 |
|
|
2021
Q3 | $199K | Hold |
20,300
| – | – | ﹤0.01% | 2723 |
|
|
2021
Q2 | $200K | Buy |
+20,300
| New | +$200K | ﹤0.01% | 2726 |
|